Patents by Inventor Tatsuroh KANEKO

Tatsuroh KANEKO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3-azabicyclo[3.1.0]hexane derivative and use thereof for medical purpose
    Patent number: 9663463
    Abstract: The object of the present invention is to provide a compound having an antagonistic action against ?-opioid receptors, which causes less side effects and thus is highly safe. A compound represented by the general formula (I), or a pharmacologically acceptable salt thereof: wherein R1 and R2 are the same or different, and each represents a hydrogen atom or a halogen atom, provided that R1 and R2 are not simultaneously halogen atoms, R3 represents a C1-C3 alkyl group or a vinyl group, and R4 represents the formula (II): wherein R5 represents a hydroxy group or a C1-C3 alkoxy group, and R6 and R7 are the same or different, and each represents a hydrogen atom or a halogen atom; or the formula (III): wherein Ring A represents a halogen atom(s)-substituted C5-C7 cycloalkyl group which is optionally substituted by a C1-C3 alkoxy group, or a halogen atom(s)-substituted 5- to 7-membered saturated heterocyclic group.
    Type: Grant
    Filed: November 19, 2014
    Date of Patent: May 30, 2017
    Assignees: SANWA KAGAKU KENKYUSHO CO., LTD., UBE INDUSTRIES, LTD.
    Inventors: Kaori Taniko, Toshiyuki Miyazawa, Tatsuroh Kaneko, Daisuke Kurumazuka, Satoko Harada, Toru Izuchi, Morio Okabe, Ryo Iwamura, Yasunori Tsuzaki, Hiroyuki Setoguchi, Yuuki Imura, Hiroto Akaza, Motohisa Shimizu, Tomio Kimura
  • NOVEL 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSE
    Publication number: 20160280645
    Abstract: The object of the present invention is to provide a compound having an antagonistic action against ?-opioid receptors, which causes less side effects and thus is highly safe. A compound represented by the general formula (I), or a pharmacologically acceptable salt thereof: wherein R1 and R2 are the same or different, and each represents a hydrogen atom or a halogen atom, provided that R1 and R2 are not simultaneously halogen atoms, R3 represents a C1-C3 alkyl group or a vinyl group, and R4 represents the formula (II): wherein R5 represents a hydroxy group or a C1-C3 alkoxy group, and R6 and R7 are the same or different, and each represents a hydrogen atom or a halogen atom; or the formula (III): wherein Ring A represents a halogen atom(s)-substituted C5-C7 cycloalkyl group which is optionally substituted by a C1-C3 alkoxy group, or a halogen atom(s)-substituted 5- to 7-membered saturated heterocyclic group.
    Type: Application
    Filed: November 19, 2014
    Publication date: September 29, 2016
    Applicants: SANWA KAGAKU KENKYUSHO CO., LTD., UBE INDUSTRIES, LTD.
    Inventors: Kaori TANIKO, Toshiyuki MIYAZAWA, Tatsuroh KANEKO, Daisuke KURUMAZUKA, Satoko HARADA, Toru IZUCHI, Morio OKABE, Ryo IWAMURA, Yasunori TSUZAKI, Hiroyuki SETOGUCHI, Yuuki IMURA, Hiroto AKAZA, Motohisa SHIMIZU, Tomio KIMURA